Sudarshan Pharma Industries Ltd strategy deck summary

Strategy deck of 15 May 2026, summarised by AI from the filing.

Sudarshan Pharma reported March 2026 quarter revenue of ₹220.92 cr and PAT of ₹10.73 cr, and targets minimum ₹100 cr exports in FY27.

Key takeaways

1. Export target Management targets minimum ₹100 cr export turnover for FY 26-27.
2. Certifications Hyderabad facility received GMP and ISO 9001:2015 certifications, enabling expansion into regulated markets.
3. China dependence High reliance on China for key APIs and intermediates exposes to supply disruptions and price rises.

Original filing on BSE

Sudarshan Pharma Industries Ltd earnings call, investor presentation and press release summaries

• Q4 FY25: Results deck (2 May 2025)
• Other events: Strategy deck (18 Aug 2026), Strategy deck (14 Aug 2026), Strategy deck (15 May 2026), Strategy deck (31 Jan 2026), Strategy deck (14 Aug 2025)